The global depyrogenated sterile empty vials market size is poised to hit around US$ 7,498.2 Mn by 2026 growing at a CAGR of 4.8% during forecast period 2019 to 2026.
Depyrogenation means the removal of pyrogens from the solution specifically from injectable pharmaceuticals. For the same, manufacturers are required to provide the certificate of sterility & pyrogen test with the final product. Depyrogenated sterile empty vials are available in the market with the capacity ranging from 1ml to 100ml. These are available in glass and plastic material such as borosilicate among others. The sterile vials can be assembled with stoppers and aluminum seals.
Market Dynamics
The increasing number of infectious & non-infectious diseases is primarily driving the market growth. According to the WHO, till 2018 75 million people were infected with the HIV virus since the beginning of the epidemic and around 32 million people have died with the virus. Additionally, at the end of the year 2018, around 37.9 million people were living with HIV. Technological advancements associated with the product technology coupled with the increasing number of collaborations in order to achieve innovative packaging technology are supporting the market value. Continuously expanding pharmaceutical and biotechnology industry is further supporting the market value. Moreover, ongoing investment in research and development activities and the increasing demand for personalized medicine is expected to create potential opportunity over the forecast period from 2019 to 2026.
On the other hand, the availability of alternatives in parenteral packaging is expected to hinder the market growth over the estimated period from 2019 to 2026.
20ml segment is having potential share in the depyrogenated sterile empty vials market
By capacity, the 20ml segment is accounted for the major share in 2018 due to the increasing usage of 20ml vials for decanting and transportation of small amounts of solvents. The increasing demand for efficient storage of parenteral formulations is further accelerating the market value.
By Material, glass segment registered the highest growth in depyrogenated sterile empty vials market
In 2018, depyrogenated sterile empty glass vials have particularly dominated the overall market. The benefits associated with the glass depyrogenated sterile empty vials such as improved chemical durability and damage resistance is particularly supporting the segment value. Moreover, these also enable effective delivery and storage of critical drug formulations by pharmaceutical and biopharmaceutical companies.
The market research study on “Depyrogenated Sterile Empty Vials Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight into the global depyrogenated sterile empty vials market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global depyrogenated sterile empty vials market, its capacity, material, end use and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global depyrogenated sterile empty vials market size and volume, and segment markets by capacity, material, end use and geography along with the information on companies operating in the market. The depyrogenated sterile empty vials market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
North America dominated the depyrogenated sterile empty vials market with major share in 2018
In 2018, the North America region accounted for the major share and the region is also expected to maintain its dominance throughout the forecast period. The increasing investment by pharma and biotech companies in R&D activities for the development of innovative packaging is primarily driving the regional market growth. The major economy of the region US is contributing a major share in the regional market due to government funding and technological progress.
The players profiled in the research report include Corning Incorporated, Thermo Fisher Scientific, APG Pharma, DWK Life Sciences, VWR International, Nipro PharmaPackaging, Gerresheimer, Merck KGaA, Radpharm Scientific, Stevanato Group, and SCHOTT. The companies were involved in mergers, acquisition and new product development strategies for expanding the portfolio and offering in the market.
Market Segmentation
Market By Capacity
- 2 ml
- 5 ml
- 10 ml
- 20 ml
- More than 20 ml
Market By Material
Market By End-Use
- Compounding Labs
- Clinical Labs
- Pharmaceutical Manufacturers
- Others (Contract manufacturing organizations, Distributors)
Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Depyrogenated Sterile Empty Vials
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Depyrogenated Sterile Empty Vials Market By Capacity
1.2.2.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Capacity (2015-2026)
1.2.2.2. Global Depyrogenated Sterile Empty Vials Market Revenue Share By Capacity in 2018
1.2.2.3. 2 ml
1.2.2.4. 5 ml
1.2.2.5. 10 ml
1.2.2.6. 20 ml
1.2.2.7. More than 20 ml
1.2.3. Depyrogenated Sterile Empty Vials Market By Material
1.2.3.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Material (2015-2026)
1.2.3.2. Glass
1.2.3.3. Plastic
1.2.4. Depyrogenated Sterile Empty Vials Market By End-user
1.2.4.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.4.2. Compounding Labs
1.2.4.3. Clinical Labs
1.2.4.4. Pharmaceutical Manufacturers
1.2.4.5. Others (Contract manufacturing organizations, Distributors)
1.2.5. Depyrogenated Sterile Empty Vials Market By Geography
1.2.5.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA) Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
CHAPTER 4. DEPYROGENATED STERILE EMPTY VIALS MARKET BY CAPACITY
4.1. Global Depyrogenated Sterile Empty Vials Revenue By Capacity
4.2. 2 ml
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. 5 ml
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. 10 ml
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. 20 ml
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. More than 20 ml
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. DEPYROGENATED STERILE EMPTY VIALS MARKET BY MATERIAL
5.1. Global Depyrogenated Sterile Empty Vials Revenue By Material
5.2. Glass
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Plastic
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. DEPYROGENATED STERILE EMPTY VIALS MARKET BY END-USER
6.1. Global Depyrogenated Sterile Empty Vials Revenue By End-user
6.2. Compounding Labs
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinical Lab
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Pharmaceutical Manufacturers
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others (Contract manufacturing organizations, Distributors)
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
7.1. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Depyrogenated Sterile Empty Vials Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
8.1. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
9.1. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
10.1. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
11.1. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Corning Incorporated
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Thermo Fisher Scientific
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. APG Pharma
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. DWK Life Sciences
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. VWR International
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Nipro PharmaPackaging
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Gerresheimer
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Merck KGaA
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Radpharm Scientific
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Stevanato Group
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. SCHOTT
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Type Portfolio
12.12.5. Key Developments
12.12.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
